Investment

Daniel Friedman

Managing Director

Daniel Friedman is a Managing Director on BroadOak's investing team, leading the firm's life science tools coverage and portfolio management function. Prior to joining BroadOak in 2019, Daniel worked for Raymond James within the Life Sciences Investment Banking team where he focused on public financings and M&A for biotechnology companies.

Daniel currently serves as a director on the boards of PBS Biotech and Precision Cell Systems, and as an observer at Axol Bioscience and Biolog. Daniel previously held board roles at Pluristyx, Avidien Technologies, and antibodies-online.